跳至主要内容
临床试验/NCT06099171
NCT06099171尚未招募3 期

Effectiveness of a Combined Therapy With Paravertebral Oxygen-ozone Injections and Topical Patch Containing Cannabidiol and β-Caryophyllene for Treatment of Neck Pain: a Prospective, Randomized, Controlled Trial.

Humanitas Clinical and Research Center1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
52
试验地点
1
主要终点
Neck Disability Index

研究概览

简要总结

The aim of this study is to compare the effectiveness of combined treatment with paravertebral oxygen-ozone injections and topical patches containing Cannabidiol and β-Caryophyllene in patients with neck pain by evaluating the following aspects:

  • Reduction of pain
  • Reduction of disability associated with neck pain

详细描述

Neck pain is a significant public health burden worldwide, with a prevalence of 2,696.5 per 100,000, and a major cause of disability, responsible for 2.56% of all years lived with disability. Many potential therapeutic interventions are available for the treatment of neck pain, including conservative therapies, minimally invasive procedures and open surgery. In particular, oxygen-ozone percutaneous injections have been tested and have proven to be well tolerated with good clinical results.

Patch cutaneous formulated with cannabidiol and β-carophyllene (Levotens®) has proven to have muscle relaxant and anti-inflammatory effects in an animal models: The tests used allow to evaluate motor performance with reference to motor coordination skills (pole test), exploration (open field test) and resistance to continuous and accelerated movement (rotarod test). These motor skills are impaired in a pain associated inflammatory response condition such as that induced by LPS (lipopolysaccharide). The CBD and BCP-based Levotens® patch placed in the area where the inflammatory stimulus is administered allows the recovery of motor function in the three types of behaviors studied.

Previous data available demonstrate a muscle relaxant action of CBD applied topically through a patch in patients suffering from TMD.

This is a randomized, controlled, prospective evaluation comparing combined treatment with paravertebral oxygen-ozone injections and topical patches containing Cannabidiol and β-Caryophyllene with only OOT. The maximum study duration for each subject will be 6 months. A total of 52 patients will be enrolled. These patients will meet specific inclusion and exclusion criteria but can be generally characterized as patients with neck pain who have been unable to achieve satisfactory pain relief with previous conservative treatments The primary study objective is to determine whether combining Levotens® Patch with OOT could lead to better early pain control than OOT alone.

  1. The primary study endpoint is to establish the improvement in NRS Pain at 14 days from the start of treatment.
  2. Secondary objectives of this study are:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Neck pain resulting from spinal pathology present for at least 1 month with or without brachial irradiation
  • •Cervical radiographic and/or MRI examination certifying the pathology of the spine
  • •Failure of previous conservative treatment (pharmacological or physiotherapy)
  • •Signing of informed consent

排除标准

  • •Specific causes of neck pain (trauma, spinal deformity, fracture, neoplasia)
  • •Central or peripheral neurological signs
  • •Rheumatic diseases: diagnosis of rheumatoid arthritis, Reiter's syndrome, psoriatic arthritis, gout, ankylosing spondylitis or arthritis secondary to other inflammatory diseases, chondrocalcinosis, Paget's disease or villonodular synovitis
  • •Neuromuscular disorders
  • •Presence of cognitive-behavioral deficit or psychiatric illness which, in the opinion of the investigator, could compromise patient safety or interfere with the evaluation of the effects of the treatment
  • •Surgery in the previous 6 months
  • •Cervical infiltrative treatments in the previous 4 months
  • •Use of orally administered systemic steroids within 2 weeks prior to screening
  • •Pregnant or breastfeeding women or women planning to become pregnant during the study participation period
  • •Known alcohol or drug dependence currently or within the past year

研究组 & 干预措施

Oxygen-Ozone Therapy

Active Comparator

The patients will undergo 8 session of oxygen-ozone therapy, 2 per week. In each session 10 cc of a gaseous mixture of oxygen-ozone (at a concentration of 10 μg of ozone per ml of oxygen) will be injected with 6 paravertebral injections.

干预措施: Oxygen-Ozone Therapy (Device)

Oxygen-Ozone Therapy plus Cannabidiol and ß-Caryophyllene Patch

Experimental

The patients will undergo 8 session of oxygen-ozone therapy, 2 per week. In each session 10 cc of a gaseous mixture of oxygen-ozone (at a concentration of 10 μg of ozone per ml of oxygen) will be injected with 6 paravertebral injections.

For the fisrt 2 weeks of oxygen-ozone therapy patients will be asked to apply patches with local action based on Cannabidiol and ß-Caryophyllene for 8-24 hours/day for 5 days/week.

干预措施: Oxygen-Ozone Therapy (Device)

Oxygen-Ozone Therapy plus Cannabidiol and ß-Caryophyllene Patch

Experimental

The patients will undergo 8 session of oxygen-ozone therapy, 2 per week. In each session 10 cc of a gaseous mixture of oxygen-ozone (at a concentration of 10 μg of ozone per ml of oxygen) will be injected with 6 paravertebral injections.

For the fisrt 2 weeks of oxygen-ozone therapy patients will be asked to apply patches with local action based on Cannabidiol and ß-Caryophyllene for 8-24 hours/day for 5 days/week.

干预措施: Cannabidiol and β-Caryophyllene Patch (Drug)

结局指标

主要结局

Neck Disability Index

时间窗: 14 days

Measure for reporting neck pain disability. It is a 10-items questionnaire; each question is scored on a 6-point scale ranging from 0 (no disability) to 5 (full disability), and these are added together to make a total score ranging from 0 to 50, which is interpreted as follows: 0 to 4= no disability, 5 to 14= mild disability, 15 to 24= moderate disability, 25 to 34= severe disability, and greater than 34 = complete disability. Evaluators can choose to provide a percentage score as a means of dealing with unanswered questions.

次要结局

  • Neck Disability Index(36 weeks)
  • Numeric Pain Rating Scale(36 weeks)

研究者

发起方
Humanitas Clinical and Research Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cristiano Sconza

Principal Investigator

Humanitas Clinical and Research Center

研究点 (1)

Loading locations...

相似试验